Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Case Report
DOI: 10.1055/s-0040-1705645
Submitted: 02-14-2022
Published: 02-14-2022

Terapia nutricional em pacientes com câncer do aparelho digestivo

Médica Pós-graduanda do CNNEP - ABRAN, 2016-2017
Nutróloga-ABRAN - Tutora
Enteral Parenteral Nutriion Therapy Cancer Digestive system

Abstract

Nutritional status in patients with cancer is a critical determinant of treatment success and life quality. Therapeutic approaches in cancer, including surgery, chemotherapy and radiation, are associated with malnutrition, and drugs used to treat cancer often result in vomiting, mucositis, diarrhea, and dysphagia. The main objective of this research is to understand the effect of nutritional interventions in GI cancer patients, analyzing several studies. For the accomplishment of this study we performed a systematic review of the literature, searching for scientific articles of the following databases PubMed, Bireme and Google academic. Results showed that neoplastic cachexia is a very common clinical manifestation in patients with GI cancer. Early nutritional therapy provides beneficial results in terms of minimizing weight loss, reducing deterioration of nutritional status, and physical function. The first nutritional choice should be the oral route. When patients are unable to ingest caloric and mainly oral protein supply, they may be candidates for NE or NP. Recent studies have suggested the association of enteral and parenteral therapies in reducing postoperative complications and in decreasing hospital stay.

Metrics

Metrics Loading ...

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
  2. Santarpia L, Contaldo F, Pasanisi F. Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle. 2011;2:27–35.
  3. Macciò A, Madeddu C, Gramignano G, Mulas C, Floris C, Sanna E, Cau MC, Panzone F, Mantovani G. A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life. Gynecol Oncol. 2012;124:417–425.
  4. Caccialanza R, Pedrazzoli P, Cereda E, Gavazzi C, Pinto C, Paccagnella A, Beretta GD, Nardi M, Laviano A, Zagonel V. Nutritional support in cancer patients: a position paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE) J Cancer. 2016;7:131–135.
  5. Nicolini A, Ferrari P, Masoni MC, Fini M, Pagani S, Giampietro O, Carpi A. Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment. Biomed Pharmacother. 2013;67:807–817.
  6. Haverkort EB, Binnekade JM, Busch OR, van Berge Henegouwen MI, de Haan RJ, Gouma DJ. Presence and persistence of nutrition-related symptoms during the first year following esophagectomy with gastric tube reconstruction in clinically disease-free patients. World J Surg. 2010;34:2844–2852.
  7. Faria C, Li X, Nagl N, McBride A. Outcomes associated with 5-HT3-RA therapy selection in patients with chemotherapy-induced nausea and vomiting: a retrospective claims analysis. Am Health Drug Benefits. 2014;7:50–58.
  8. Maranzano E, De Angelis V, Pergolizzi S, Lupattelli M, Frata P, Spagnesi S, Frisio ML, Mandoliti G, Malinverni G, Trippa F, Fabbietti L, Parisi S, Di Palma A, De Vecchi P, De Renzis C, Giorgetti C, Bergami T, Orecchia R, Portaluri M, Signor M, Di Gennaro D, Italian Group for Antiemetic Research in Radiotherapy - IGARR A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. Radiother Oncol. 2010;94:36–41.
  9. Yang ZH and Li GN. Clinical Analysis of Perioperative Enteral Nutrition in Patients with Gastrointestinal Tumor. App J Gen Prac 2008; 6: 483-484.
  10. Ahn HS, Yook JH, Park CH, Park YK, Yu W, Lee MS, Sang-Uk H, Ryu KW, Sohn TS, Kim HH, Choi SH, Noh SH, Hiki N, Sano T and Yang HK. General perioperative management of gastric cancer patients at high-volume centers. Gastric Cancer 2011; 14: 178-182.
  11. Lassen K, Dejong CH, Ljungqvist O, Fearon K, Andersen J, Hannemann P, von Meyenfeldt MF, Hausel J, Nygren J and Revhaug A. Nutritional support and oral intake after gastric resection in five northern European countries. Dig Surg 2005; 22: 346-352; discussion 352.
  12. Klein S, Koretz RL. Nutrition support in patients with cancer: what do the data really show? Nutr Clin Pract 1994;9:91-100.
  13. Altintas ND, Aydin K, Türkoğlu MA, et al. Effect of enteral versus parenteral nutrition on outcome of medical patients requiring mechanical ventilation. Nutr Clin Pract 2011;26:322-9.
  14. Peterson, Sarah J., and Marisa Mozer. “Differentiating Sarcopenia and Cachexia Among Patients With Cancer.” Nutrition in Clinical Practice 32.1 (2017): 30-39.
  15. Bevan R, Young C, Holmes P, Fortunato L, Slack R, Rushton L. British Occupational Cancer Burden Study Group. Occupational cancer in Britain. Gastrointestinal cancers: liver, oesophagus, pancreas and stomach. Br J Cancer. 2012;107(Suppl 1):S33–40.
  16. Reid J, McKenna HP, Fitzsimons D, McCance TV. An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals. Eur J Cancer Care. 2010;19:682–9.
  17. SUN, Li-Chu et al. Randomized, controlled study of branched chain amino acid-enriched total parenteral nutrition in malnourished patients with gastrointestinal cancer undergoing surgery. The American Surgeon, v. 74, n. 3, p. 237-242, 2008.
  18. Bozzetti F, Mariani L. Defining and classifying cancer cachexia: a proposal by the SCRINIOWorking Group. JPEN Journal of Parenteral and Enteral Nutrition 2009;33(4):361–7.
  19. Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Klek, S., ... & Waitzberg, D. (2017). ESPEN guideline: Clinical nutrition in surgery. Clinical Nutrition.
  20. Bozzetti F, Arends J, Lundholm K, et al. ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr. 2009; 28: 445-54.
  21. Arends J, Bodoky G, Bozzetti F, et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr. 2006; 25: 245–259.
  22. August DA, Huhmann MB; American Society for Parenteral and Enteral Nutrition (ASPEN) Board of Directors. ASPEN clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN. 2009; 33:472-500.
  23. French Speaking Society of Clinical Nutrition and Metabolism (SFNEP). Clinical nutrition guidelines of the French Speaking Society of Clinical Nutrition and Metabolism (SFNEP): Summary of recommendations for adults undergoing non-surgical anticancer treatment. Dig Liver Dis. 2014 46:667-74.
  24. Weimann A, Braga M, Harsanyi L et al. ESPEN Guidelines on Enteral Nutrition: surgery including organ transplantation. Clin Nutr. 2006; 25: 224-44.
  25. SHILS, Maurice E.; SHIKE, Moshe; ROSS, A. Catharine; CABALLERO, Benjamin, COUSINS, Robert J. Nutrição moderna na saúde e na doença. 11ª edição, São Paulo: Manole, 2016.
  26. Bozzetti F. Nutritional support of the oncology patient. Crit Rev Oncol Hematol. 2013; 87: 172-200.
  27. Bossola M. Nutritional intervention in head and neck cancer patients undergoing chemoradiotherapy: a narrative review. Nutrients. 2015; 7: 265-76.
  28. Cao DX, Wu GH, Zhang B, et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clinical Nutrition 2010;29:72–7.
  29. Fredrix EW, Soeters PB, Wouters EF, Deerenberg IM, von Meyenfeldt MF, Saris WH. Effect of different tumor types on resting energy expenditure. Cancer Research 1991;51:6138–41.
  30. Arends, Jann et al. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition, 2016.
  31. Shaw JH, Holdaway CM. Protein-sparing effect of substrate infusion in surgical patients is governed by the clinical state, and not by the individual substrate infused. JPEN Journal of Parenteral and Enteral Nutrition 1988;12:433–40.
  32. G. Zürcher, U. Gola, H.K. Biesalski. Antioxidanzien bei Krebs. Schweiz Z für Ernährungsmedizin, 4 (2007), pp. 17–19.
  33. H.A. Norman, R.R. Butrum, E. Feldman, D. Heber, D. Nixon, M.F. Picciano, et al. The role of dietary supplements during cancer therapy. J Nutr, 133 (Suppl. 11) (2003), pp. S3794–S3799.
  34. Silva, Juliana de Aguiar Pastore, Maria Emilia de Souza Fabre, Dan Linetzky Waitzberg. Omega-3 supplements for patients in chemotherapy and/or radiotherapy: A systematic review. Clinical Nutrition 34.3 (2015): 359-366.
  35. Deans DA, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, Paterson-Brown S, Fearon KC. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer. 2009;100:63–9.
  36. Deans DA, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, PatersonBrown S, Fearon KC. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 2009; 100: 63-9.
  37. Churm D, Andrew IM, Holden K, Hildreth AJ, Hawkins C. A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 2009; 17: 503-7.
  38. Wu Q, Yu JC, Kang WM, Ma ZQ. Short-term effects of supplementary feeding with enteral nutrition via jejunostomy catheter on postgastrectomy gastric cancer patients. Chin Med J 2011; 124: 3297- 301.
  39. Jeong O, Ryu SY, Jung MR, Choi WW and Park YK. The safety and feasibility of early postoperative oral nutrition on the first postoperative day after gastrectomy for gastric carcinoma. Gastric Cancer 2014; 17: 324-331.
  40. HUANG, Dongping et al. Early enteral nutrition in combination with parenteral nutrition in elderly patients after surgery due to gastrointestinal cancer. International journal of clinical and experimental medicine, v. 8, n. 8, p. 13937, 2015.
  41. Elamin E. Dietary and pharmacological management of severe catabolic conditions. Am J Med Sci 2011; 342: 513-8.
  42. Moses AW, Slater C, Preston T, Barber MD, Fearon KC. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. British Journal of Cancer 2004;90(5):996–1002.
  43. DUDRICK, S. J. et al. Long-term total parenteral nutrition with growth, development and positive nitrogen balance. Surgery 1968. 64: 134-142. Nutr. Hosp, v. 16, n. 6, p. 286-292, 2001.
  44. Reid J, Mills M, Cantwell M, Cardwell CR, Murray LJ, Donnelly M. Thalidomide for managing cancer cachexia. Cochrane Database Syst Rev 2012; 4: CD008664.

How to Cite

Godoi, L. T., & Fernandes, S. L. (2022). Terapia nutricional em pacientes com câncer do aparelho digestivo. International Journal of Nutrology, 10(4), 136–144. https://doi.org/10.1055/s-0040-1705645